59088-795 NDC - DERMALOGICA OIL CONTROL ()

Drug Information

  • Product NDC: 59088-795
  • Proprietary Name: Dermalogica Oil Control
  • Non Proprietary Name:
  • Active Ingredient(s): 200 mg/1 ACETYLCYSTEINE; 47 mg/1 CALCIUM CITRATE; 800 [iU]/1 CHOLECALCIFEROL; 1000 ug/1 FOLIC ACID; 16 mg/1 MAGNESIUM CITRATE
  • Administration Route(s):
  • Dosage Form(s):
  • Pharmacy Class(es): Antidote [EPC]; Antidote for Acetaminophen Overdose [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations; Divalent [CS]; Decreased Respiratory Secretion Viscosity [PE]; Increased Coagulation Factor Activity [PE]; Increased Glutathione Concentration [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Mucolytic [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Reduction Activity [MoA]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Vitamin D [CS]; Vitamin D [EPC]

Labeler Information

Field Name Field Value
Labeler Name: PureTek Corporation
Product Type:
FDA Application Number: part333D
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date:11/17/2003
End Marketing Date:5/26/2011

Package Information

No. Package Code Package Description Billing Unit
159088-795-051 TUBE in 1 CARTON (59088-795-05) / 22 mL in 1 TUBE
259088-795-5430 TABLET in 1 BOTTLE, PLASTIC (59088-795-54)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC59088-795The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEDermalogica Oil ControlThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE11/17/2003This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEOTC MONOGRAPH FINALProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEPureTek CorporationName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC59088-795The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEFolcyteineThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE9/14/2023This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED DRUG OTHERProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEPureTek CorporationName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025